来自MSN5 天
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
Engineered to specifically act on the vascular endothelial growth factor receptor 2 (VEGFR2), BR55 (perfluorobutane/nitrogen ...
Nature2 年
Bracco Brings Cardiac PET Imaging to More Providers
launched its Bracco Mobile Isotope Service (BMIS) program in 2021 to address this and other challenges to offering cardiac PET imaging for patients. The service provides CardioGen-82® (Rubidium ...
Nature4 年
Bracco’s technology and leadership improves cardiac disease diagnosis and mangement
Bracco is a family-owned business based on imaging for CT, MRI, X-ray, ultrasound and nuclear medicine. Our mission is to offer products that help identify diagnostic solutions for patients.
Yahoo Finance6 天
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit ...
Monthly Prescribing Reference7 天
VEGFR2-Binding Contrast Agent Fast Tracked for Crohn Disease Assessment
According to Bracco Imaging, the safety and efficacy of BR55 for detecting active bowel inflammation in Crohn disease will soon be evaluated in large-scale phase 3 trials. Bracco Imaging receives ...